Candidaemia and cancer: Patients are not all the same

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Pasqualotto, Alessandro Comarú ^a,e   Rosa, Daniela Dornelles ^b   Medeiros, Lidia Rosi ^c   Severo, Luiz Carlos ^d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d Mycology Laboratory   (Brazil)

^e NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CARBAPENEM; CEPHALOSPORIN; CLINDAMYCIN; CORTICOSTEROID; GLYCOPEPTIDE; METRONIDAZOLE; ANTIFUNGAL AGENT;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAZIL; CANCER GRADING; CANCER MORTALITY; CANDIDIASIS; CENTRAL VENOUS CATHETER; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; GASTROINTESTINAL SURGERY; HEMATOLOGIC DISEASE; HODGKIN DISEASE; HUMAN; ILEUS; INFANT; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL INFORMATION; NEUTROPENIA; NONHODGKIN LYMPHOMA; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; FUNGEMIA; MIDDLE AGED; NEOPLASM; PRESCHOOL CHILD; RISK;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FUNGEMIA; HUMANS; INFANT; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33645570425     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-50     Document Type: Article

References (28)

1. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002, 34:730-751.
2. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens O, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ: Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34:7-14.
3. DiNubile MJ, Hille D, Sable CA, Kartsonis NA: Invasive candidiasis in cancer patients: observations from a randomized clinical trial. J Infect 2005, 50:443-449.
4. Pasqualotto AC, Nedel WL, Machado TS, Severo LC: A 9-year study comparing risk factors and the outcome of paediatric and adults with nosocomial candidaemia. Mycopathologia 2005, 160:111-116.
5. Pasqualotto AC, Nedel WL, Machado TS, Severo LC: A comparative study of risk factors and outcome among outpatient-acquired and nosocomial candidaemia. J Hosp Infect 2005, 60:129-134.
6. Pasqualotto AC, Nedel WL, Machado TS, Severo LC: Risk factors and outcome for nosocomial breakthrough candidaemia. J Infect 2005, 52:216-222.
7. Hosmer DW, Lemeshow S: Applied logistic regression. New York: John Wiley, 1989.
8. Maksymiuk NA, Thongprasert S, Hopfer R, Luna M, Finstein V, Bodey GP: Systemic candidiasis in cancer patients. Am J Med 1984, 77:S20-27.
9. Nucci M, Silveira MI, Spector N, Silveira F, Velasco E, Martins CA, Derossi A, Colombo AL, Pulcheri W: Fungemia in cancer patients in Brazil: predominance of non-albicans species. Mycopathologia 1998, 141:65-68.
10. Schwartz RS, Mackintosh FR, Schrier SL, Greenberg PL: Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer 1984, 53:411-419.
11. Shoham S, Levitz SM: The immune response to fungal infections. Br J Haematol 2005, 129:569-582.
12. Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Vandercam B, Doyen C, Lebeau B, Spence D, Krcméry V, De Pauw B, Meunier F: Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999, 28:1071-1079.
13. Torres HA, Kontoyiannis DP, Rolston KV: High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study. Support Care Cancer 2004, 12:511-516.
14. Bodey GP: Candidiasis in cancer patients. Am J Med 1984, 77:S13-19.
15. Pasqualotto AC, Severo LC: Why don't we just do what we have to do? J Infect 2005, 51:260-261.
16. Bodey G, Bueltmann B, Duguid W, Hanak H, Hotchi M, Mall G, Martino P, Meunier F, Milliken S, Naoe S, Okudaira M, Scevola D, Wout van't J: Fungal infections in cancer patients. An international autopsy survey. Eur J Clin Microbial & Infect Dis 1992, 11:99-109.
17. Karabinis A, Hill C, Leclercq B, Tancrede C, Baume D, Andremont A: Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol 1988, 26:429-432.
18. Kovacicova G, Spanik S, Kunova A, Trupl J, Sabo A, Koren P, Sulcova M, Mateicka F, Novotny J, Pichnova E, Jurga L, Chmelik B, Obertik T, West D, Krcméry V Jr: Prospective study of fungaemia in a single cancer institution over a 10-y period: aetiology, risk factors, consumption of antifungals and outcome in 140 patients. Scand J Infect Dis 2001, 33:367-374.
19. Krcméry V Jr, Mrazova M, Kunova A, Grey E, Mardiak J, Jurga L, Sabo A, Sufliarsky J, Sevcikova L, Sorkovska D, West D, Trupl J, Novotny J, Mateicka F: Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution. Support Care Cancer 1999, 7:428-431.
20. Richet HM, Andremont A, Tancrede C, Pico JL, Jarvis WR: Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis 1991, 13:211-215.
21. Kralovicova K, Spanik S, Oravcova E, Mrazova M, Morova E, Gulikova V, Kukuckova E, Koren P, Pichna P, Nogova J, Kunova A, Trupl J, Krcméry V Jr: Fungemia in cancer patients undergoing chemotherapy versus surgery: risk factors, aetiology and outcome. Scand J Infect Dis 1997, 29:301-304.
22. Bodey GP, Mardani M, Hanna HA, Boktour M, Abbas J, Girgawy E, Hachem RY, Kontoyiannis DP, Raad II: The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med 2002, 112:380-385.
23. Trupl J, Kunova A, Oravcova E, Pichna P, Kukuckova E, Grausova S, Grey E, Spanik S, Demitrovicova A, Kralovicova K, Lacka J, Krupova I, Svec J, Koren P, Krcméry V Jr: Resistance pattern of 2816 isolates isolated from 17631 blood cultures and etiology of bacteremia and fungemia in a single cancer institution. Acta Oncol 1997, 36:643-649.
24. Marr KA: The changing spectrum of candidemia in oncology patients: therapeutic implications. Curr Opin Infect Dis 2000, 13:615-620.
25. Antunes AGV, Pasqualotto AC, Diaz MC, d'Azevedo PA, Severo LC: Candidemia in a Brazilian tertiary care hospital: species distribution and antifungal susceptibility patterns. Rev Inst Med trop S Paulo 2004, 46:239-241.
26. Goldani LZ, Mário PSS: Candida tropicalis fungemia in a tertiary care hospital. J Infection 2003, 46:155-160.
27. Kontoyiannis DP, Vaziri I, Hanna HA, Boktour M, Thornby J, Hachem R, Bodey GP, Raad II: Risk factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis 2001, 33:1676-1681.
28. Slavin MA: The epidemiology of candidaemia and mould infections in Australia. J Antimicrob Chemother 2002, 49(Suppl 1):3-6.